Trials / Completed
CompletedNCT00995813
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
Pilot Study of the Safety and Immunogenicity of the Rotavirus Vaccine in Infants With Intestinal Failure
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Seattle Children's Hospital · Academic / Other
- Sex
- All
- Age
- 6 Weeks – 14 Weeks
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and immune response of the rotavirus vaccine in infants who have undergone abdominal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Rotarix | A rotavirus vaccine (Rotarix) will be administered in two doses, 8 weeks apart, in infants between 6 and 14 weeks of age. The standard dosage is 1 mL administered orally or per gastrostomy tube. |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2012-05-01
- Completion
- 2013-07-01
- First posted
- 2009-10-15
- Last updated
- 2015-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00995813. Inclusion in this directory is not an endorsement.